-+ 0.00%
-+ 0.00%
-+ 0.00%

Beta Bionics Chief Commercial Officer Mark Hopman Sells $16,420 in Common Shares

PUBT·10/28/2026 20:04:14
Listen to the news
Beta Bionics Chief Commercial Officer Mark Hopman Sells $16,420 in Common Shares
  • Beta Bionics Chief Commercial Officer Mark Hopman sold 821 shares of common stock at $20 each.
  • The October 26, 2026, transaction left Hopman with 54,513 shares held directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002048497-26-000023), on October 28, 2026, and is solely responsible for the information contained therein.